期刊文献+

经皮冠状动脉介入治疗术中无复流现象防治研究进展 被引量:3

Progression of no-reflow prevention and treatment in percutaneous coronary intervention
下载PDF
导出
摘要 随着经皮冠状动脉介入治疗方法在临床上得到广泛应用,急性ST段抬高性心肌梗死直接经皮冠状动脉介入治疗(PCI)的比例越来越高。但急诊PCI过程中,常常发生无复流现象,严重影响患者的预后。本文就无复流的可能机制和处理作一简要介绍。 As percutaneous coronary intervention is widely used in clinic,more and more acute ST-segment elevation myocardial infarction patients undergo direct PCI.However,no-reflow phenomenon seriously affects the prognosis of patients during emergent PCI.The possible mechanisms and therapies of no-reflow phenomenon will be introduced briefly in this review.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第5期595-600,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 经皮冠状动脉介入 无复流 慢血流 血管扩张剂 血小板糖蛋白受体拮抗剂 血栓抽吸 远端保护装置 Percutaneous coronary intervention No-reflow Slow reflow Vasodilator agents Platelet glycoprotein receptor antagonist Thrombus aspiration Distal protection equipment
  • 相关文献

参考文献27

  • 1Abbo KM, Dooris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coro nary intervention [J]. Am J Cardiol, 1995, 75 (12): 778-782.
  • 2Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention[J]. Circulation, 1994, 89 (6) 2514-2518.
  • 3Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct related arteries and timely reperfusion in acute myocardial infarction: predictors of slow flow and no-reflow phenomenon [J]. Chest, 2002, 122(4): 1322-1332.
  • 4Kenner M, Zajace J, Kondos GT, et al. Ability of the no-fellow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one month follow-up[J]. Am J Cardiol, 1995, 76(12): 861-868.
  • 5Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine ecbocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction[J]. Circulation, 1993, 88 (2) : 405-415.
  • 6Sanchis J, Munoz J, Chorro FJ, et al. Stunned myocardium after thrombolytic treatment. Identification by dobutamine echocardiography and role of the residual stenosis in the infarction artery[J]. Int J Cardiol, 1996, 53(1): 5-13.
  • 7Matetzky S, Freimark D, Chouraqui P, et al. The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion [J]. J Am Coil Cardiol, 1998, 32(5) : 1326-1330.
  • 8Zeymer U, Schrode R, Tebbe U, et al. Non-invasive detection of early infarct vessel patency by resolution of ST-Segment elevation in patients with thrombolysis for acute myocardial infaretion[J. Eur Heart J, 2001, 22(9): 769-775.
  • 9Vijayalakshmi K, Whittaker VJ, Kunadian B, et al. Prospective, randomized, controlled trial to study the effect of intraeoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes[J]. Heart, 2006, 92 (9) : 1278-1284.
  • 10Parikh KH, Chag MC, Shah KJ, et al. Intraeoro- nary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty., a clinical scenario of ischemic preconditioning [J]. Can J Physiol Pharmacol, 2007, 85(3/4): 476-482.

同被引文献35

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部